[1]
“THE TREATMENT OF MULTIPLE MYELOMA PATIENTS NOT ELIGIBLE FOR ASCT”, Mediterr J Hematol Infect Dis, vol. 2, no. 2, p. e2010009, May 2010, doi: 10.4084/mjhid.2010.009.